Matt Posard

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
12 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Matt Posard's trades of Halozyme Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
54.15
Quantity 30,000
Value US$1,624,500
Transaction date
Proposed sale
Price
50.00
Quantity 20,000
Value US$1,000,000
Transaction date
Purchase
Price
4.45
Quantity 10,000 +25.0%
Value US$44,493
Transaction date
Purchase
Price
4.46
Quantity 10,000 +33.3%
Value US$44,612
Transaction date
Purchase
Price
4.50
Quantity 10,000 +50.0%
Value US$45,000
Transaction date
Purchase
Price
4.57
Quantity 20,000 +inf%
Value US$91,400
Transaction date
Purchase
Price
16.00
Quantity 62,500 +inf%
Value US$1,000,000
US DermTech Inc (DMTK)
Transaction date
Purchase
Price
29.50
Quantity 33,898 +64.0%
Value US$999,991
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-16
PlS Planned sale
75,100 +44.4%
326.63
US$1,435,737 		75,100 +44.4% 326.63 US$1,435,737
2026-09-17 2026-09-16
PlS Planned sale
89,067 +1.9%
415.56
US$2,350,983 		89,067 +1.9% 415.56 US$2,350,983
2026-09-17 2026-09-16
PlS Planned sale
57,124 +11.6%
151.12
US$4,084,935 		57,124 +11.6% 151.12 US$4,084,935
2026-09-17 2026-09-16
PlS Planned sale
3,100 -4.0%
106.13
US$329,009 		3,100 -4.0% 106.13 US$329,009
2026-09-16 2026-09-16
PrS Proposed sale
34,226
106.25
US$3,636,512 		34,226 106.25 US$3,636,512
2024-08-14 2024-08-14
S Sale
9,881 -12.4%
57.70
US$570,134 		9,881 -12.4% 57.70 US$570,134
2024-08-14 2024-08-13
S Sale
10,000 -11.1%
56.19
US$561,930 		10,000 -11.1% 56.19 US$561,930
2024-08-07 2024-08-13
PrS Proposed sale
30,000
54.15
US$1,624,500 		30,000 54.15 US$1,624,500
2024-08-14 2024-08-12
S Sale
10,000 -10.0%
55.72
US$557,230 		10,000 -10.0% 55.72 US$557,230
2024-06-13 2024-06-12
S Sale
10,000 -9.1%
50.62
US$506,190 		10,000 -9.1% 50.62 US$506,190
2024-06-13 2024-06-11
S Sale
10,000 -8.4%
50.01
US$500,110 		10,000 -8.4% 50.01 US$500,110
2024-06-11 2024-06-11
PrS Proposed sale
20,000
50.00
US$1,000,000 		20,000 50.00 US$1,000,000
2022-12-06 2022-12-06
S Sale
10,000 -8.7%
56.12
US$561,180 		10,000 -8.7% 56.12 US$561,180
2022-12-06 2022-12-05
S Sale
10,000 -8.0%
55.74
US$557,370 		10,000 -8.0% 55.74 US$557,370
2022-12-06 2022-12-02
S Sale
10,000 -7.4%
58.80
US$588,000 		10,000 -7.4% 58.80 US$588,000
2021-12-01 2021-12-01
B Purchase
10,000 +25.0%
4.45
US$44,493 		10,000 +25.0% 4.45 US$44,493
2021-12-01 2021-12-01
B Purchase
10,000 +33.3%
4.46
US$44,612 		10,000 +33.3% 4.46 US$44,612
2021-12-01 2021-12-01
B Purchase
10,000 +50.0%
4.50
US$45,000 		10,000 +50.0% 4.50 US$45,000
2021-12-01 2021-11-30
B Purchase
20,000 +inf%
4.57
US$91,400 		20,000 +inf% 4.57 US$91,400
2021-02-19 2021-02-17
B Purchase
62,500 +inf%
16.00
US$1,000,000 		62,500 +inf% 16.00 US$1,000,000
2021-01-13 2021-01-11
US DermTech Inc (DMTK)
B Purchase
33,898 +64.0%
29.50
US$999,991 		33,898 +64.0% 29.50 US$999,991